SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-23-001083
Filing Date
2023-05-31
Accepted
2023-05-31 16:34:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3380
  Complete submission text file 0001950047-23-001083.txt   4883
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address
Gallagher Cam (Reporting) CIK: 0001557832 (see all company filings)

Type: 144

Mailing Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Subject) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39263 | Film No.: 23981495
SIC: 2834 Pharmaceutical Preparations